Aegerion Pharmaceuticals (AEGR -10.1%) says it plans a public offering of 3.4M shares of common...

|About: Aegerion Pharmaceuticals (AEGR)|By:, SA News Editor

Aegerion Pharmaceuticals (AEGR -10.1%) says it plans a public offering of 3.4M shares of common stock at $14.75/share, as it looks to raise funds for activities related to the regulatory approval and commercialization of its lipid disorder treatment and lead product candidate lomitapide.